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Wednesday, February 29, 2012 599aenhance their interaction with the biological environment can help achieve tar-
geting, triggered self-assembly, remote actuation with radiofrequency fields,
sensing of kinase activity, and delivery of short interfering RNAs. In collabo-
ration with Erkki Ruoslahti (Burnham Institute), we have explored how deco-
rating the surface with peptides obtained from in vivo phage display can alter
the properties of these nanoparticles and control their trafficking. To increase
the accumulation of the nanoparticles at the tumor site we are exploring
in vivo self-assembly of these particles. Our approach is inspired by platelets_
natural microparticles that normally circulate in a latent form but can home to
sites of injury and transform to an activated state, whereby they adhere and re-
cruit more platelets. This results in assemblies of magnetic nanoparticles that
may then acquire emergent properties, allowing either their enhanced visuali-
zation or remote actuation of drug delivery. More recently, we have also emu-
lated biological systems where biological components remotely communicate
via biological intermediates. The resultant nanoparticle formulations then act
as a ‘‘system’’ to produce emergent behaviors for enhancing diagnosis and
therapy.
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In 1965, Gordon Moore, co-founder of Intel, described the trend that the num-
ber of components in integrated circuits had doubled every year since 1958.
This trend has continued to today, enabled by advances in photolithography
which has taken the minimum feature size of transistors down from about
10 microns in 1970 to 0.045 microns (45 nm) today. In biological terms,
this corresponds to going from the size of a red blood cell to the size of a sin-
gle virus particle! As such, this top-down nano-fabrication technology from
the semiconductor industry is, for the first time, in the size range to be rele-
vant for the design of medicines, vaccines and interfacially active Janus par-
ticles. This lecture will describe the design, synthesis and efficacy of organic
nano- and micro-particles using a top-down nano-fabrication technique we de-
veloped called PRINT (Particle Replication in Non-wetting Templates).
PRINT is a continuous, roll-to-roll, high resolution molding technique that al-
lows the fabrication of precisely defined micro- and nano-particles in a contin-
uous manner with control over chemical composition, size, shape,
deformability and surface chemistry. With these ‘nanotools’, we are establish-
ing definitive biodistribution maps to elucidate the interdependent roles that
size, shape, deformability and surface chemistry play on particle distribution
as a function of different dosage forms (IV, IP, inhaled, subcutaneous, intra-
muscular, etc). This information is setting the stage for the design of highly
effective chemo-therapeutics, chemo-preventions and cancer vaccines which
will be described.
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Cancer is a dynamic condition in a complex community of cells which move
and communicate in 3-D space and complex topologies. We will present results
using 3-Dmicrofabrication and materials science which maps out how the com-
munity moves and invades.
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A variety of organic and inorganic materials have been utilized to generate
nanoparticles for drug delivery applications, including polymeric nanopar-
ticles, dendrimers, nanoshells, liposomes, nucleic acid based nanoparticles,
magnetic nanoparticles, and virus nanoparticles. The two most commonly
used systems are polymeric nanoparticles and liposomes. Controlled release
polymer technology has impacted virtually every branch of medicine, includ-
ing ophthalmology, pulmonary, pain medicine, endocrinology, cardiology, or-
thopedics, immunology, neurology and dentistry, with several of these systems
in clinical practice today such as Atridox, Lupron Depot, Gliadel, Zoladex,
Trelstart Depot, Risperidol Consta and Sandostatin LAR. The annual world-
wide market of controlled release polymer systems which extends beyond
drug delivery is now estimated at $100 billion and these systems are used
by over 100 million people each year. Polymeric nanoparticles can deliver
drugs in the optimum dosage over time, thus increasing the efficacy of the
drug, maximizing patient compliance and enhancing the ability to use highly
toxic, poorly soluble, or relatively unstable drugs. These systems can also beused to co-deliver two or more drugs for combination therapy. The surface en-
gineering of these nanoparticles may yield them ‘‘stealth’’ to prolong their res-
idence in blood and the functionalization of these particles with targeting
ligands can differentially target their delivery or uptake by a subset of cells,
further increasing their specificity and efficacy. More recently combinatorial
approaches have been developed to precisely engineer nanoparticles and
screen multiple nanoparticle characteristics simultaneously with the goal of
identifying formulations with the desired physical and biochemical properties
for each specific application. The goal of this talk is to review our efforts in the
design and optimization of polymeric nanoparticles for medical applications,
which formed the foundation for the clinical translation of the first-in-
human targeted and controlled-release nanoparticles (BIND-014) for cancer
therapy.Platform: Emerging Single Molecule Techniques
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Deciphering the dynamic nature of biological processes requires developing
tools for monitoring the behavior of single molecules (SMs) in live cells. How-
ever, a key challenge lies in the difficulty of imaging and tracking SM in
three dimensions, notably for intracellular proteins that tend to diffuse rapidly
(> 0.5 um2/s). Methods currently employed for sub-diffraction 3D localization
of individual fluorophores are limited to an axial depth of ~1 um or less. Here
we present a novel multifocal microscope that permits the rapid (up to
30 frames/s) acquisition of 3D stacks. The microscope is based on the incorpo-
ration in the emission pathway of a multi-focus diffraction grating combined
with a chromatic-correction grating in order to simultaneously detect 9 differ-
ent axial planes on a single detector camera. Thereby, the system allows for
aberration-free detection of individual molecules over an axial distance of up
to 5 um. The microscope characteristics are particularly appropriate for probing
the dynamics of individual molecules in the nucleus of cultured cells. This ca-
pability is demonstrated by recording the 3Dmotion of individual inert markers
(beads or quantum dots), mRNAs, histone H2B proteins or transcription factors
in live mammalian cells. Overall, our multifocal microscope, with its ease of
use and performances, holds great promise for fast and sensitive 3D imaging
in many cellular contexts.
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Efficient self-assembly of the bacterial 30S ribosomal subunit depends on the
interplay of a large number of sequential RNA folding and protein binding
events. In many cases the order of these events is not rigidly defined, giving
rise to an assembly landscape crossed by parallel assembly pathways. The bi-
ological and biophysical implications of parallel assembly are unclear, and
seem to contradict the current understanding of the ways large RNAs avoid ki-
netic traps. There has been very little direct characterization of the degree of
parallel assembly in ribosomes because current biophysical techniques have
difficulty resolving intermediates, especially with a large macromolecule
(>500kDa) that requires high concentrations (100-1000nM) to assemble.
To quantitate 30S intermediates, Fluorescence Correlation Spectroscopy (FCS)
was extended to create Fluorescence Triple Correlation Spectroscopy (F3CS).
By correlating three signals, F3CS can study complex stoichiometric systems,
kinetic processes and irreversible reactions. Theory, numerical correlation
strategies, and experimental practices were established and a two-photon exci-
tation, three-color detection microscope was built to perform the first F3CS
measurements. The technique is implemented as a suite of software, Triple Cor-
relation Toolbox, to enable triple correlation experiments with existing
microscopes.
F3CS simultaneously identified intermediates both on and off the ribosome as-
sembly pathways that were predicted by classic assembly maps. A weak ener-
getic bias favors one assembly pathway over the others, but the bias energy is
not strong enough to prevent the formation of intermediates off of the favored
pathway. The interaction energies of ribosomal proteins S7, S9 and S19 are ini-
tially weak, which in principle reduces the potential for kinetic traps. F3CS has
